RUO Disclaimer: All QRM products are strictly for in vitro laboratory and research use only by qualified researchers in appropriate facilities. Nothing here implies, suggests, or recommends any diagnostic, therapeutic, or clinical application or use in humans or animals.
- SSL Secured
- Secure Checkout
- Guaranteed Delivery
- Third-Party Tested
GLOW
A research blend combining BPC-157, TB-500, and GHK-Cu for researchers studying complementary regenerative and cellular signaling pathways simultaneously. Three of the most referenced compounds in tissue and skin biology research, formulated together.
$100.00
- +99% Purity
- Third-Party Tested
- COA Available
- SSL Secured
- Secure Checkout
- Guaranteed Delivery
- Third-Party Tested
A research blend combining BPC-157, TB-500, and GHK-Cu for researchers studying complementary regenerative and cellular signaling pathways simultaneously. Three of the most referenced compounds in tissue and skin biology research, formulated together.
About GLOW
GLOW brings together three peptides with well-documented roles in tissue biology, each operating through distinct but complementary signaling pathways. Rather than relying on a single mechanism, GLOW is formulated to target dermal and follicular tissue at multiple biological levels in research models, from collagen scaffolding and vascular signaling to cellular migration and follicular pathway activity.
GHK-Cu, a naturally occurring copper-binding tripeptide, has been studied extensively for its ability to modulate gene expression related to dermal tissue remodeling at the cellular level. Research suggests it activates signaling pathways associated with collagen and connective tissue synthesis, antioxidant defense, and the regulation of enzymes responsible for clearing and remodeling damaged tissue in controlled research settings.
BPC-157, derived from a protective protein studied in gastric tissue research models, has been investigated across a broad range of tissue types for its role in healing and vascular signaling. In dermal and connective tissue research contexts, studies have examined its effects on fibroblast activity, angiogenic signaling, and the upregulation of growth factor receptors relevant to tissue repair pathway activity in vitro.
TB-500, a synthetic analogue of the naturally occurring peptide Thymosin Beta-4, has been studied for its role in actin regulation, cell migration, and tissue repair signaling. Research in wound healing models has examined its potential to accelerate re-epithelialization and support new vessel formation in damaged tissue research models, with particular relevance to scalp and follicular environment signaling.
Mechanism of Action
- GHK-Cu has been researched for its role in upregulating collagen I, collagen III, and elastin, the structural proteins studied for their contribution to skin firmness and elasticity in dermal tissue research models. It has also been studied for its modulation of enzymes that break down and clear aging or damaged tissue, a process investigated as necessary for organized new tissue formation at the cellular level.
- BPC-157 has been studied for its interaction with the VEGF signaling pathway, a key regulator of blood vessel formation in tissue research models. By promoting endothelial cell activity in vitro, it has been investigated for its potential to influence vascular density, a factor studied for its relevance to nutrient and oxygen delivery in dermal and follicular tissue research contexts. BPC-157’s influence on nitric oxide signaling has also been examined for its potential to amplify the vascular effects of both GHK-Cu and TB-500 in skin and scalp tissue research models.
- TB-500 has been investigated for its regulation of beta-actin, a protein that governs how cells move and reorganize during repair processes in controlled research settings. Studies have examined its effects on the migration of keratinocytes and fibroblasts, two cell types investigated for their roles in wound closure and connective tissue repair signaling. The combination of GHK-Cu and TB-500 has been studied for complementary effects on tissue remodeling, with GHK-Cu investigated for structural matrix signaling activity while TB-500 is studied for the cell migration pathway activity needed to populate and organize regenerating tissue in laboratory research models.
Research Highlights
GHK-Cu is one of the most studied peptides in dermatological research, with studies examining its capacity to stimulate fibroblast proliferation and upregulate collagen synthesis signaling genes in laboratory research models. Its copper-chelating properties have also been investigated for their role in supporting lysyl oxidase activity, an enzyme studied for its relevance to collagen cross-linking pathway function in vitro.
BPC-157 and TB-500 have been independently researched for their pro-angiogenic signaling properties, with BPC-157 studied for VEGF-VEGFR2 pathway activation and TB-500 investigated for endothelial cell differentiation activity. Together these mechanisms have been examined in research contexts relevant to scalp microcirculation and follicular nutrient signaling in preclinical research models.
GHK-Cu has been studied in follicular miniaturization research models, with studies examining its effects on follicular keratinocyte activity and its potential to influence follicle cycling between telogen and anagen phases at the cellular level. TB-500's role in keratinocyte migration adds a complementary signaling dimension relevant to follicular re-population studies in controlled research settings.
GLOW's three-component framework has been studied for whether concurrent activation of structural, vascular, and migratory signaling pathways produces a more comprehensive tissue repair research profile than any single component achieves in isolation. GHK-Cu, BPC-157, and TB-500 each carry established individual research profiles in wound healing and tissue remodeling, with investigators examining their combined activity as a systems-level research model in experimental settings.
Product Specifications
- Molecular Formula
- See individual peptide pages
- Molecular Weight
- See individual peptide pages
- CAS #
- See individual peptide pages
- Sequence
- GHK-Cu, BPC-157, TB-500 (see individual peptide pages)
- Purity
- ≥99% (HPLC verified)
- Form
- Lyophilized powder
- Appearance
- Blue powder
- Solubility
- Universal Solvent
- Storage
- -20°C (lyophilized), 2-8°C (after preparation)
Reference
- Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015). GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International, 2015, 648108.
- Sikiric, P., Seiwerth, S., Rucman, R., et al. (2013). Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 17(16), 1612–1632.
- Goldstein, A. L., Hannappel, E., Sosne, G., & Kleinman, H. K. (2012). Thymosin β4: A multi-functional regenerative peptide. Expert Opinion on Biological Therapy, 12(1), 37–51.
